Non-Melanoma Skin Cancers Coverage from Every Angle

Recent News

KEYNOTE-629: Pembrolizumab in Metastatic Cutaneous Squamous Cell Carcinoma
Front-Line Immunotherapy for Locally Advanced Basal Cell Carcinoma: Case Studies
Sex-Dependent Distribution of Non-Melanoma Skin Cancers of the Pinna
Sun Health Behaviors and Skin Cancer Risk in Children: Public Health Report From Ireland
Case Study Features Association Between Rare Skin Condition and Basal Cell Carcinoma
Identifying High-Risk Patients With Cutaneous Squamous Cell Carcinoma for Clinical Trial
Health-Related Quality of Life With Cemiplimab for Skin Cancer
Call to Action: Skin Cancer Surveillance in Patients With Organ Transplants
AACR II: Linking HPV Infection to Skin Cancer in Patients With CLL
Immune-Mediated Adverse Events With Concomitant Radiotherapy and Immunotherapy
AACR II: Does Cyclooxygenase-2 Inhibitor Use Reduce the Risk of Skin Cancer?
AACR II: Early Tanning Bed Use and Risk for Skin Cancer
Pembrolizumab Approved by FDA for Cutaneous Squamous Cell Carcinoma
AACR II: Do Permanent Hair Dyes Increase the Risk of Skin Cancer?
ASCO20: Upfront Treatment With Cemiplimab for Locally Advanced Skin Cancer
Preclinical Study of Plant Flavonoid in Treatment of Squamous Cell Skin Cancer
ASCO20: Longer-Term Follow-Up Supports Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
ASCO20: Predicting Subclinical Progression of Squamous Cell Carcinoma
ASCO20: Total-Body Skin Exams and Diagnosis of Skin Cancers
ASCO20: Targeting MDM2 in Merkel Cell Carcinoma
ASCO20: Preserving Eye Function in Locally Advanced Orbital/Periocular Basal Cell Carcinoma
Skin Cancer Awareness Month: Recommendations for Prevention
Managing Patients With Skin Cancer During the COVID-19 Pandemic
Exploring Staph Bacteria’s Connection to Growth of Skin Cancers
DDW 2020: Risk of Skin Cancer in Patients With Inflammatory Bowel Disease
COVID-19 and Skin Cancer: Meeting Clinical Challenges in Dermatology
Non-Melanoma Skin Cancer: A Continual Problem for Outdoor Workers
STAT3 Pathway: Therapeutic Target in Cutaneous Squamous Cell Carcinoma?
Pembrolizumab Receives FDA Accelerated Approval for Alternative Dosing Schedule
Does Narrowband UV-B Therapy Increase Risk for Non-Melanoma Skin Cancer?
Moffitt Researchers Identify Tumor Suppressors in Cutaneous Squamous Cell Carcinoma
Could Artificial Intelligence Be the Future for Skin Cancer Screening?
Is Pembrolizumab Active in Treatment of Advanced Skin Cancer?
Electrochemotherapy With Reduced-Dose Bleomycin in Elderly Patients With Skin Cancer
Superficial Radiation Therapy and Non-Melanoma Skin Cancer
Molecular Role of Cox-2 in Cutaneous Squamous Cell Carcinoma
Association Between Mercury Exposure and Non-Melanoma Skin Cancer
Nonsurgical Treatment for Invasive Cutaneous Squamous Cell Carcinoma: A Case Study
Researchers Identify New Genomic Areas Potentially Linked to Increased Skin Cancer Risk
Rates of Skin Cancer Among Sexual Minorities
GW Cancer Center: Site of Clinical Trial of Cemiplimab in High-Risk Skin Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.